Market Insights — 22 Oct 2026

IPO Updates

Today's IPO landscape reveals strong interest, particularly for Jio Platforms, which is currently trading with a GMP of 21.98%. This indicates robust demand among investors. Paras Healthcare is also open for subscription with a GMP of 3.61%. On the horizon, BLS Polymers and SFC Environmental Technologies are upcoming IPOs, boasting GMPs of 20.0% and 9.39%, respectively.

Market Performance

Listed stocks are showing mixed results today. Fusion CX has gained 4.67%, reflecting positive market sentiment. Meanwhile, Ravita Engineering Services has modestly increased by 0.89%. These movements suggest a cautious but optimistic approach among investors.

Commodity Rates

In the commodities market, gold is priced at ₹14,607 per 10 grams, down slightly by ₹1. Silver remains at ₹179.56 per kg, indicating stability in the precious metals sector. Investors should keep an eye on these rates as they can influence broader market trends.

FII and DII Flows

Foreign Institutional Investors (FIIs) have net inflows of ₹1,022.32 crore, while Domestic Institutional Investors (DIIs) are showing stronger support with net inflows of ₹1,614.32 crore. This trend suggests a healthy appetite for equities, particularly from domestic sources.

Top Mutual Funds

For those considering mutual funds, the Franklin India Short Term Income Plan stands out with a remarkable annual return of 192.1% across various plans (Retail Direct - Quarterly, Monthly, and Weekly). These funds have earned a solid 5-star rating, highlighting their performance and reliability.

Recent Market News

Recent headlines emphasize the dynamic nature of the market. Notably, a multibagger stock has declared its Q2 results for 2026, boasting a staggering 750% increase over the last decade. Meanwhile, India’s private investment pipeline has surged to ₹99.7 lakh crore, driven by growth in IT services and power sectors. As inflation concerns loom with rising oil prices, Indian shares are anticipated to open lower, reflecting cautious sentiment.

Investors are encouraged to conduct thorough research and consider these insights as part of their investment strategy. The GMP figures are unofficial and indicative; this briefing does not constitute investment advice. For live updates and more detailed data, visit topfund.in.